{
    "2019-08-04": [
        [
            {
                "time": "",
                "original_text": "微评丨医疗影响力排行榜：雁栖健谈、健康160、通策医疗",
                "features": {
                    "keywords": [
                        "医疗",
                        "影响力排行榜",
                        "雁栖健谈",
                        "健康160",
                        "通策医疗"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【西南医药|2019中报点评】通策医疗（600763）：业绩强劲增长，“蒲公英计划”顺利推进",
                "features": {
                    "keywords": [
                        "西南医药",
                        "2019中报",
                        "通策医疗",
                        "业绩强劲增长",
                        "蒲公英计划"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}